Treatment of Cardiovascular Diseases - North America
North America- In North America, specifically United States, the Treatment of Cardiovascular Diseases market is expected to see significant growth in revenue.
- By 2024, the projected revenue for this market is estimated to reach an impressive US$136.00bn.
- Looking ahead, the market is expected to continue expanding at an annual growth rate of 3.35% between 2024 and 2029.
- This steady growth will result in a market volume of approximately US$178.00bn by 2029.
- In North America, the use of advanced imaging techniques for diagnosing and monitoring cardiovascular diseases is on the rise.
Definition:
Treatments of Cardiovascular Diseases refers to the treatment of patients with diseases or disorders that affect the circulatory system, including coronary artery disease, heart disease, and stroke. During their stay in the hospital, patients are provided with necessary surgical procedures, medication management, and any medical intervention that is needed to manage their symptoms, prevent complications, and further progression of the disease, thus improving their overall health and well-being.
Additional information:
The Treatments of Cardiovascular Diseases market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Diagnostic testing
- Medication received during inpatient treatments
- Continuous monitoring, such as tracking heart rate or blood pressure
- Interventional procedures, such as angioplasty or stenting
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
